全球卵圓孔未閉合封堵器市場：市場規模、佔有率和趨勢分析（2026-2032 年）

全球卵圓孔未閉合封閉裝置市場報告（至2032年）

2025年全球卵圓孔閉合裝置的市場規模為4.979億美元。預計該市場將以5.5%的複合年成長率成長，到2032年達到7.247億美元。

本報告涵蓋了卵圓孔未閉合（PFO）封堵裝置的全球市場，包括用於治療心臟兩個心房之間間隔缺損的裝置。

分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

微創導管介入手術的普及、臨床顯著性卵圓孔未閉（PFO）診斷準確率的提高以及人們對PFO與不明原因卒中之間關聯的認知不斷加深，是推動市場成長的主要因素。然而，長期臨床數據的缺乏、診斷率低以及未來進入左心房的挑戰，仍阻礙該技術的進一步應用。

市場概覽

全球卵圓孔封堵器市場包括用於封堵卵圓孔未閉（PFO）的裝置。卵圓孔未閉是指位於心臟左右心房之間的小孔。雖然許多卵圓孔未閉患者沒有症狀，但有些患者俱有臨床意義，尤其是在不明原因缺血性中風或其他栓塞事件後接受評估的患者中。

PFO封堵器經由微創導管植入。這些產品使專家無需開胸手術即可封鎖缺損，從而減輕手術帶來的身體負擔，縮短住院時間和恢復時間。

在全球範圍內，人們對卵圓孔未閉（PFO）與不明原因卒中之間關聯的認知不斷提高，促使診斷率有所提升，尤其是在成年患者中。卒中篩檢診斷流程的改進預計將支持需要治療的病例數量持續成長。

影像技術的進步，包括心臟超音波圖和經顱都卜勒超音波，提高了臨床上顯著性卵圓孔未閉（PFO）的識別準確性。雖然對嬰兒進行PFO常規篩檢並非標準做法，但在中風評估過程中診斷準確性的提高預計將在整個預測期內維持對PFO封堵器的需求。

市場促進因素

微創手術

微創治療是卵圓孔未閉（PFO）封堵器市場的主要驅動力。傳統上，PFO手術需要開胸手術，這不僅創傷更大，而且恢復期也更長。

PFO封堵器使專科醫生能夠透過導管介入手術進行封鎖。這種方法更受歡迎，因為它能減輕疼痛、縮短住院時間並減輕患者的復原負擔。

此外，微創手術使得治療病情嚴重的患者或那些不適合接受開放性手術的患者成為可能。這擴大了實際接受治療的患者範圍，並促進了卵圓孔未閉封堵裝置的持續廣泛應用。

人們對卵圓孔未閉和不明原因中風的認知不斷提高

全球許多市場對卵圓孔未閉（PFO）與不明原因中風之間聯繫的認知正在不斷提高。這一點尤其重要，因為許多患有PFO的患者在進行中風相關檢查之前並無症狀。

隨著越來越多的臨床醫生在評估不明原因缺血性中風時考慮卵圓孔未閉（PFO），預計診斷率將有所提高。這將擴大符合治療條件的患者群體，並增加對該手術的需求。

可治療的卵圓孔未閉（PFO）患者群仍集中在那些發生過不明原因缺血性中風或伴隨栓塞事件的患者中。隨著神經科醫生、循環系統和中風團隊對PFO認知的提高，預計會有更多患者被轉診進行評估，並考慮是否適合進行卵圓孔未閉封堵術。

改善診斷流程

診斷技術的進步正在推動卵圓孔未閉封堵器市場的成長。心臟超音波圖和經顱都卜勒等影像技術提高了識別具有臨床意義的卵圓孔未閉的準確性。

這些檢查有助於臨床醫生評估卵圓孔未閉是否與患者的中風病史或栓塞風險有關。診斷信心的提升有助於制定治療方案和轉診模式。

儘管對普通人群的篩檢仍然有限，但卒中篩檢的改進有望提高最有可能從閉合手術中獲益的患者的診斷率。這將導致治療病例數在2032年之前穩定成長。

市場限制

缺乏臨床數據

缺乏長期臨床數據仍是卵圓孔未閉封堵器市場的主要阻礙因素。雖然短期內使用卵圓孔未閉封堵器治療中風患者已相對成熟，但一些研究表明，與單獨使用抗凝血治療相比，該療法可降低未來中風的風險；

然而，包括戈爾公司進行的REDUCE、CLOSE和RESPECT試驗在內的近期臨床試驗的長期療效仍有爭議。對長期療效缺乏完全信心可能會限制該技術在預測期內的應用。

此外，支持卵圓孔未閉（PFO）封堵術治療偏頭痛的臨床數據有限。 MIST、PRIMA 和 PREMIUM 三項試驗均顯示陰性結果，儘管 PREMIUM 試驗證實 PFO 封堵術後偏頭痛發作次數有所減少。在獲得更確鑿的數據之前，PFO 封堵術在偏頭痛相關適應症方面的核准和應用可能仍將受到限制。

PFO患者的診斷率低

大多數卵圓孔未閉患者沒有症狀。因此，大多數病例未被診斷和治療。

截至2025年，可治療的卵圓孔未閉（PFO）患者群仍主要集中在發生不明原因缺血性中風或其他栓塞事件的患者中。 PFO通常在卒中後的診斷評估中被發現。

儘管人們對卵圓孔未閉（PFO）的認知不斷提高，影像技術也取得了進步，但與普通人群中的估計盛行率相比，PFO 的總體診斷和治療率仍然很低。這限制了市場擴張，因為許多 PFO 患者沒有接受封堵術評估。

與未來進入相關的挑戰

未來進入左心房的途徑是卵圓孔未閉封堵器市場的另一個阻礙因素。隨著經皮手術的增加，例如經皮二尖瓣介入治療和左心耳封堵術，醫生未來可能需要透過房間隔進入左心房。

PFO封堵裝置可能會使未來進入左心房更加困難。這會影響醫師的決策，尤其對於未來可能需要接受結構性心臟疾病或電生理介入治療的患者。

在生物可吸收性卵圓孔未閉封堵器上市之前，這種擔憂可能會限制某些手術。臨床醫師必須權衡封堵的益處與未來可能需要再次手術的風險。

市場範圍和數據範圍

• 定量範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
• 定性範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
• 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
• 建立市場模型：收入分析採用銷售量和平均售價（ASP），並輔以治療量、競爭市場佔有率分析和預測假設。
• 目標裝置：本報告重點在於用於治療心臟兩個心房之間間隔缺損的卵圓孔閉合裝置。

目標市場及區隔

卵圓孔未閉通暢性術市場

本報告涵蓋了全球卵圓孔閉合裝置市場，作為心臟外科手術和結構性心臟疾病器械的細分市場。

卵圓孔未閉封堵器用於封閉心臟心房之間的開口。這些裝置經由導管手術植入，最常用於某些有不明原因缺血性中風或栓塞風險的患者。

此市場分析依據市場規模、市場佔有率、治療次數、市場預測、市場成長率、銷售量及平均售價。

本報告根據診斷率、中風篩檢途徑、微創手術的可及性、臨床證據、醫生偏好、報銷條件以及對未來可及性的考慮來評估需求。

這種結構有助於製造商、投資者和策略團隊了解臨床應用案例、診斷路徑、長期證據和競爭定位如何塑造全球 PFO 封堵器市場。

競爭分析

2025年，雅培是全球卵圓孔未閉封堵器市場的主要企業。該公司提供Amplatzer™卵圓孔未閉封堵器。

雅培憑藉早期進入市場確立了其領先地位。 Amplatzer™平台擁有強大的市場佔有率，其優勢包括易於醫生操作、市場覆蓋範圍廣，以及在基於導管的卵圓孔未閉封堵術中持續應用。

2025年，戈爾公司是全球卵圓孔未閉封堵器市場第二大競爭對手。該公司提供「Gore® Cardioform 房間隔封堵器」。

Gore® Cardioform 房間隔封堵器已在歐洲核准用於心房中膈缺損症和卵圓孔未閉。雖然該器械鞏固了 Gore 在結構性心臟疾病封堵領域的地位，但一些區域性公司在全球市場的存在限制了該公司的業務擴張。

競爭格局主要由擁有成熟技術、醫生認可度和國際分銷網路的老字型大小企業主導。然而，全球業務擴張取決於區域核准情況、臨床證據、當地競爭對手以及中風和結構性心臟疾病治療計畫的採用趨勢。

科技和醫療治療的發展趨勢

導管輔助閉合術

導管輔助卵圓孔未閉封堵術仍是市場上的主要臨床趨勢。這些手術無需開胸即可完成封堵，從而減輕了手術帶來的身體負擔並縮短了術後恢復期。

這種微創方法是其得以持續廣泛應用的關鍵。

納入中風篩檢

卵圓孔未閉（PFO）的診斷與隱源性中風（病因不明的卒中）的調查密切相關。當患者發生病因不明的缺血性中風時，臨床醫師可能會評估是否有PFO病變。

預計該途徑仍將是接受卵圓孔未閉治療的患者的主要來源。

醫學影像技術的改進

經食道超音波心臟超音波圖和經顱都卜勒超音波篩檢提高了檢測具有臨床意義的前列腺卵泡功能障礙（PFO）的準確性。

影像技術的進步使得診斷更加準確，並幫助臨床醫生識別可能受益於閉合手術的患者。

選擇性患者治療

由於許多卵圓孔未閉（PFO）患者並無症狀，因此治療需視情況而定。對於有中風病史或曾發生栓塞事件導致PFO具有臨床意義的患者，封堵術是最佳選擇。

因此，符合治療條件的患者人數將少於 PFO 的估計總患病人數。

長期結果的考察

長期療效仍在研究中。醫生和保險公司將繼續評估臨床試驗數據，以確定哪些患者最能從閉合手術中受益。

對長期結果信心的增強可能會促進更廣泛的應用。

未來左心房通道規劃

隨著左側手術的增加，未來進入左心房的途徑變得越來越重要。卵圓孔未閉（PFO）封堵術可能會使後續的二尖瓣、左心耳（LAA）手術或消融術變得複雜。

這一趨勢未來可能會增加人們對生物可吸收縫合技術的興趣。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

• 目前全球卵圓孔閉合裝置的市場規模有多大？預計到 2032 年將成長多少？
• 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
• PFO封堵裝置在治療有栓塞風險的心房中膈缺損症中扮演什麼角色？
• 對卵圓孔未閉和不明原因中風的認知如何影響診斷和治療？
• 經食道超音波心臟超音波圖和經顱都卜勒篩檢如何提高病患識別率？
• 微創導管治療為何能推動此療法的廣泛應用？
• 哪些長期臨床數據的挑戰仍在限制其廣泛應用？
• 為什麼無症狀卵圓孔未閉患者的低診斷率阻礙了市場擴張？
• 未來左心房通路需求將如何影響卵圓孔未閉（PFO）的封堵決定？
• 全球卵圓孔未閉封堵器市場的主要企業有哪些？

iData Research 的《全球卵圓孔封堵器市場報告》透過設備層面的分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告將幫助您評估需求、比較競爭對手、了解結構性心臟疾病封堵術的趨勢，並制定全球卵圓孔封堵器市場的產業計畫。

目錄

調查方法

• 第一步：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 第四步：進行初步調查
• 第五步：調查與分析：建立基準估計值
• 第六步：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟九：客戶回饋與市場監測

全球關稅的影響

閉塞閉合裝置的市場

• 執行摘要
  • 全球卵圓孔閉合裝置市場概覽
  • 競爭分析
  • 目標程式
  • 目標區域
• 介紹
• 手術次數
• 市場分析與預測
• 促進因素和抑制因素
• 競爭性市佔率分析

附錄

Global Patent Foramen Ovale Closure Device Market Report to 2032

The global patent foramen ovale closure device market was valued at $497.9 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.5%, reaching $724.7 million by 2032.

This report covers the global market for patent foramen ovale (PFO) closure devices, including devices used to treat a defect in the septum between the two atrial chambers of the heart.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by minimally invasive catheter-based procedures, improved diagnosis of clinically relevant PFOs, and increased awareness of the link between PFO and cryptogenic stroke. However, limited long-term clinical data, low diagnosis rates, and future left atrial access challenges continue to limit stronger adoption.

Market Overview

The global patent foramen ovale closure device market includes devices used to close a PFO, a small opening between the right and left atria of the heart. While many PFOs are asymptomatic, some are clinically relevant, especially in patients evaluated after cryptogenic ischemic stroke or other embolic events.

PFO closure devices are delivered through a minimally invasive catheter-based approach. These products allow specialists to close the defect without open surgery, reducing procedural trauma, hospital stay, and recovery time.

Globally, increased awareness of the association between PFO and cryptogenic stroke has improved diagnostic rates, especially in adult patient populations. Improved diagnostic pathways in stroke workups are expected to support continued growth in treated cases.

Advances in imaging modalities, including transesophageal echocardiography and transcranial Doppler screening, have improved identification of clinically relevant PFOs. While routine screening of infants for PFO is not standard practice, better diagnosis during stroke evaluation is expected to sustain demand for PFO closure devices over the forecast period.

Market Drivers

Minimally Invasive Procedures

Minimally invasive treatment is the main driver of the PFO closure device market. PFO procedures were traditionally performed through open surgery, which required more invasive access and longer recovery.

PFO occluders allow specialists to perform closure through a catheter-based procedure. This approach is favored because it can reduce pain, shorten hospital stays, and limit the burden of recovery for patients.

Minimally invasive procedures also make treatment possible for patients who may be too sick or high-risk to undergo open surgery. This expands the practical treatment population and supports continued adoption of PFO closure devices.

Increased Awareness of PFO and Cryptogenic Stroke

Awareness of the relationship between PFO and cryptogenic stroke has improved in many global markets. This is especially important because many patients with PFO remain asymptomatic until the defect is identified during a stroke-related workup.

As more clinicians consider PFO during evaluation of unexplained ischemic stroke, diagnosis rates are expected to improve. This supports a larger treated patient pool and increases procedural demand.

The treatable PFO population remains concentrated among patients who have experienced cryptogenic ischemic stroke or related embolic events. As awareness grows among neurologists, cardiologists, and stroke teams, more patients may be referred for evaluation and potential closure.

Improved Diagnostic Pathways

Advances in diagnostic pathways are supporting growth in the PFO closure device market. Imaging modalities such as transesophageal echocardiography and transcranial Doppler screening have improved identification of clinically relevant PFOs.

These tools help clinicians evaluate whether a PFO may be related to a patient's stroke history or embolic risk. Better diagnostic confidence can support treatment decisions and referral patterns.

Although general population screening remains limited, improved stroke workups are expected to increase diagnosis of patients most likely to benefit from closure. This supports steady growth in treated cases through 2032.

Market Limiters

Lack of Clinical Data

Limited long-term clinical data remains a key restraint in the PFO closure device market. The use of PFO closure devices to treat stroke patients is relatively well established in the short term, with trials showing reduced likelihood of future strokes compared with anticoagulation therapy alone.

However, debate continues around long-term outcomes from recent trials, including the Gore REDUCE, CLOSE, and RESPECT trials. This lack of full confidence in long-term outcomes may limit adoption over the forecast period.

There is also limited clinical data supporting PFO closure for migraine treatment. The MIST, PRIMA, and PREMIUM trials showed negative results, although the PREMIUM trial did show a reduction in migraine days after PFO closure. Until stronger data is available, approval and use for migraine-related indications will remain limited.

Low Diagnosis Rate for Patients with PFO

Most individuals with a PFO remain asymptomatic. As a result, a large proportion of cases go undiagnosed and untreated.

As of 2025, the treatable PFO population remains mainly concentrated among patients who have experienced cryptogenic ischemic stroke or other embolic events. PFOs are most often identified during post-stroke diagnostic evaluations.

Despite improved awareness and better imaging tools, the overall diagnosis and treatment rate remains low compared with the estimated prevalence of PFO in the general population. This limits market expansion because many patients with PFO are never evaluated for closure.

Future Access Challenges

Future access to the left atrium is another limiter for the PFO closure device market. As left-sided procedures grow, including percutaneous mitral valve interventions and left atrial appendage closure, physicians may need future access through the atrial septum.

A PFO closure device can make future access to the left atrium more challenging. This may influence physician decision-making, especially in patients who could require future structural heart or electrophysiology procedures.

Until a bioresorbable PFO closure device is available on the open market, this concern may limit some procedures. Clinicians may weigh the benefit of closure against the possibility of future access needs.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers patent foramen ovale closure devices used to treat a defect in the septum between the two atrial chambers of the heart.

Markets Covered and Segmentation

Patent Foramen Ovale Closure Device Market

The report covers the global patent foramen ovale closure device market as a dedicated cardiac surgery and structural heart device segment.

PFO closure devices are used to close an opening between the atrial chambers of the heart. These devices are placed through a catheter-based procedure and are most commonly used in selected patients with cryptogenic ischemic stroke or embolic risk.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

The report evaluates demand based on diagnosis rates, stroke workup pathways, minimally invasive procedure adoption, clinical evidence, physician preference, reimbursement conditions, and future access considerations.

This structure helps manufacturers, investors, and strategy teams understand how clinical use cases, diagnostic pathways, long-term evidence, and competitive positioning are shaping the global PFO closure device market.

Competitive Analysis

Abbott was the leading competitor in the global PFO closure device market in 2025. The company offers the Amplatzer(TM) PFO Occluder.

Abbott's early presence in the market has supported its leadership position. The Amplatzer(TM) platform is well established and benefits from physician familiarity, broad market presence, and continued use in catheter-based PFO closure procedures.

Gore was the second-leading competitor in the global PFO closure device market in 2025. The company offers the Gore(R) Cardioform Septal Occluder.

The Gore(R) Cardioform Septal Occluder is approved for atrial septal defect and PFO closure in Europe. The device supports Gore's position in structural heart closure, although regional companies limit the company's expansion in some global markets.

The competitive landscape is led by established companies with proven occluder technologies, physician familiarity, and international distribution. However, global expansion depends on regional approvals, clinical evidence, local competitors, and adoption patterns within stroke and structural heart programs.

Technology and Practice Trends

Catheter-Based Closure

Catheter-based PFO closure remains the core practice trend in the market. These procedures allow closure without open surgery, reducing procedural trauma and recovery burden.

This minimally invasive approach is central to continued adoption.

Stroke Workup Integration

PFO diagnosis is increasingly tied to cryptogenic stroke workups. When patients experience unexplained ischemic stroke, clinicians may evaluate whether a PFO could be involved.

This pathway is expected to remain the main source of treated PFO patients.

Improved Imaging

Transesophageal echocardiography and transcranial Doppler screening are improving detection of clinically relevant PFOs.

Better imaging supports more accurate diagnosis and helps clinicians identify patients who may benefit from closure.

Selective Patient Treatment

Because many PFOs are asymptomatic, treatment is selective. Closure is most relevant for patients with stroke history or embolic events where the PFO is believed to be clinically meaningful.

This keeps the treatable population smaller than the estimated total PFO prevalence.

Long-Term Outcomes Review

Long-term outcomes remain under review. Physicians and payers continue to evaluate trial data to understand which patients benefit most from closure.

Greater confidence in long-term outcomes would support broader adoption.

Future Left Atrial Access Planning

Future access to the left atrium is becoming more important as left-sided procedures increase. PFO closure may complicate later access for mitral, LAA, or ablation procedures.

This trend may support future interest in bioresorbable closure technologies.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global patent foramen ovale closure device market today, and how much is it expected to grow through 2032?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• What role do PFO closure devices play in treating atrial septal defects linked to embolic risk?
• How is awareness of PFO and cryptogenic stroke affecting diagnosis and treatment?
• How are transesophageal echocardiography and transcranial Doppler screening improving patient identification?
• Why are minimally invasive catheter-based procedures driving adoption?
• What long-term clinical data questions still limit broader use?
• Why does the low diagnosis rate for asymptomatic PFO patients constrain the market?
• How could future left atrial access needs affect PFO closure decisions?
• Which companies lead the global PFO closure device market?

The Global Patent Foramen Ovale Closure Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand structural heart closure trends, and support commercial planning in the global PFO closure device market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Patent Foramen Ovale Closure Device Market

• 21.1 Executive Summary
  • 21.1.1 Global Patent Foramen Ovale Closure Device Market Overview
  • 21.1.2 Competitive Analysis
  • 21.1.3 Procedures Included
  • 21.1.4 Regions Included
• 21.2 Introduction
• 21.3 Procedure Numbers
• 21.4 Market Analysis And Forecast
• 21.5 Drivers And Limiters
  • 21.5.1 Market Drivers
  • 21.5.2 Market Limiters
• 21.6 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 21-1: Patent Foramen Ovale Closure Device Market, Global, 2025 & 2032
• Chart 21-2: Patent Foramen Ovale Closure Device Procedures, Global, 2025
• Chart 21-3: Patent Foramen Ovale Closure Procedures by Region, Global, 2022 - 2032
• Chart 21-4: Patent Foramen Ovale Closure Device Market, Global, 2022 - 2032
• Chart 21-5: Leading Competitors, Patent Foramen Ovale Closure Device Market, Global, 2025

LIST OF FIGURES

• Figure 21-1: Patent Foramen Ovale Closure Procedures Covered
• Figure 21-2: Patent Foramen Ovale Closure Device Regions Covered, Global (1 of 2)
• Figure 21-3: Patent Foramen Ovale Closure Device Regions Covered, Global (2 of 2)
• Figure 21-4: Patent Foramen Ovale Closure Procedures by Region, Global, 2022 - 2032
• Figure 21-5: Patent Foramen Ovale Closure Procedures by Country, North America, 2022 - 2032
• Figure 21-6: Patent Foramen Ovale Closure Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 21-7: Patent Foramen Ovale Closure Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 21-8: Patent Foramen Ovale Closure Procedures by Country, Western Europe, 2022 - 2032
• Figure 21-9: Patent Foramen Ovale Closure Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 21-10: Patent Foramen Ovale Closure Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 21-11: Patent Foramen Ovale Closure Procedures by Country, Middle East, 2022 - 2032
• Figure 21-12: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 21-13: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 21-14: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 21-15: Patent Foramen Ovale Closure Procedures by Country, Africa, 2022 - 2032
• Figure 21-16: Patent Foramen Ovale Closure Device Market, Global, 2022 - 2032
• Figure 21-17: Units Sold by Region, Patent Foramen Ovale Closure Device Market, Global, 2022 - 2032
• Figure 21-18: Average Selling Price by Region, Patent Foramen Ovale Closure Device Market, Global, 2022 - 2032 (US$)
• Figure 21-19: Market Value by Region, Patent Foramen Ovale Closure Device Market, Global, 2022 - 2032 (US$M)
• Figure 21-20: Leading Competitors, Patent Foramen Ovale Closure Device Market, Global, 2025